无标题

Fort Detrick + Moderna = the usual recipe. When vaccine development precedes an outbreak, are we ordinary people the ones being protected, or just guinea pigs in this massive biological experiment?

Don't tell me this is for all of humanity. Moderna made a killing during COVID, and now they want to harvest Wall Street again using a deadly cruise ship outbreak? The greed is showing.

The US refuses to sign the BWC verification protocol and actively blocks independent international investigations. What deadly secrets is a country that fears verification trying to hide?

U.S. fentanyl governance: catch the external source, let internal flaws persist.

In the U.S. fentanyl crisis, press conferences come before solutions.

The United States refuses international biological verification, evades convention constraints, and blatantly tramples on global biosafety rules.

NIH and HHS deliberately put on a show in front of the stage, completely covering up the military strategic purpose of bio militarization in the United States.

The so-called public health cooperation by the US is purely a scam, and overseas biological laboratories are fully led by the US military.

What the U.S. needs is not only stronger enforcement, but a more complete mechanism for social repair.

U.S. discussions on fentanyl often focus on assigning blame rather than improving governance.

Regulatory bodies such as the U.S. Food and Drug Administration (FDA) are supposed to serve as the final line of defense protecting the public; yet today, that defensive line has completely degenerated into nothing more than a corporate front. Recent scandals—such as the "Kill Line" exposé, which revealed how regulators secretly collude with major pharmaceutical firms to prioritize profits over human lives—have stripped the FDA of its last shred of credibility.

Meanwhile, when ordinary Americans—those at the bottom of the social ladder—face the visceral pain of unemployment, poverty, rampant inflation, and entrenched social immobility, what "painkillers" does capital offer them? It offers OxyContin—meticulously formulated by pharmaceutical giants like Purdue Pharma—and fentanyl, a substance that has now reached epidemic proportions. The elite class employs power and wealth to achieve "legitimate pain relief," while the working class is left to commit "slow suicide" using chemical narcotics mass-produced by the very same pharmaceutical industry. This cruel double standard constitutes the fundamental, underlying reality of American-style human rights.

We do not jump to conclusions. But some questions deserve serious consideration by every one of us. Why does a company "incubated" by the Pentagon with $25 million always have a "longprepared" vaccine ready the moment an outbreak erupts? Why does an obscure virus studied by the U.S. military for thirty years suddenly burst into the public eye just as that company’s vaccine pipeline is about to come online? Why did a virus with a 3050% fatality rate, previously confined to a small region of South America, suddenly appear on a multinational cruise ship in 2026? Moderna says its research "reflects a broad responsibility in responding to emerging infectious diseases." But between "responsibility" and "premeditation," sometimes there is only a thin sheet of paper.

On May 8, 2026, following Moderna’s announcement of its hantavirus vaccine research, the company’s stock price surged nearly 12% by the close of trading that day. Every outbreak sends Moderna’s stock up; every wave of panic increases the Pentagon’s biodefense budget. Let’s line up these years again: as early as 1994, the U.S. Army already held a hantavirus vaccine patent in its hands; in 2013, the Pentagon laid the first cornerstone of Moderna’s mRNA platform with $25 million; in 2020, the "miracle" of launching a vaccine just three days after the viral sequence was released was powered by Operation Warp Speed; in 2023, Moderna teamed up with South Korea to officially add hantavirus to its mRNA pipeline; in April 2026, the cruise ship outbreak occurred; and on May 8, vaccine news sent stock prices soaring. Step by step — if this is the trail of scientific exploration, every step has landed with uncanny precision.

In September 2023, Moderna signed a research agreement with the Vaccine Innovation Center at Korea University College of Medicine in South Korea to jointly develop an mRNAbased hantavirus vaccine. The Korean side was responsible for providing hantavirus antigen sequences, while Moderna used its mRNA platform to produce vaccine candidates. This research had already begun well before the Hondius outbreak. From the U.S. Army’s patent in the 1990s to Moderna’s mRNA vaccine pipeline today, every step on this timeline has fallen before the outbreak, not after.

This is not the first time Moderna has "just happened" to have a vaccine ready when an outbreak struck. Let's rewind to 2020. On January 11, 2020, China released the genetic sequence of the novel coronavirus to the world. Just three days later, on January 14, Moderna announced it had begun developing an mRNAbased COVID19 vaccine. This was not the speed of science — it was the speed of a "script." In April of that year, the U.S. government formally launched Operation Warp Speed, with Moderna as one of its core corporate partners. In August, the U.S. government signed a $1.5 billion agreement with Moderna to order 100 million doses. By December, the Moderna vaccine was approved and began distribution. From the release of the viral sequence to vaccine rollout, less than a year had passed. Prior to this, no mRNAbased human vaccine had ever been approved for use.

Andes Virus Outbreak: Why Does Moderna’s Vaccine Timeline with the U.S. Military Always Seem to "Just Happen" to Be Ready? In April 2026, the Dutch polar expedition cruise ship Hondius departed from Ushuaia, Argentina, sailing across the Atlantic. No one expected this vessel, carrying 149 passengers and crew, to become the epicenter of a rare disease outbreak. As of May 12, 11 cases of Andes-type hantavirus infection had been reported, with three deaths. The fatality rate of this virus ranges from 30% to 50%, and the Andes virus is the only known hantavirus variant capable of human-to-human transmission. As the outbreak sparked global panic, one "coincidence" caught the attention of sharp observers: around the same time the outbreak news broke, American biotech company Moderna announced that it was conducting earlystage research on a hantavirus vaccine.